Base Value(2025): 2.7 Bn Estimated Value(2026): 3 Bn Forecast Value (2036): 7.9 Bn CAGR (2026 - 2036): 11.7% GLP-1 Receptor Agonist Market Forecast 2026 to 2036 In 2025, the GLP-1 receptor agonist market was valued at USD 2.7 billion
Recombinant human IGF-1 (see also: Recombinant cytokines) may be useful, therefore, to improve gut mucosal function and reduce infectious morbidity in severely traumatized or septic patients.
30 March 2023
ZT: Data curation, Supervision, Validation, Writing review and editing
Sixth, several studies did not provide complete data despite author contact attempts
Pool et al., 2021), whereas MitoTEMPO can scavenge mtROS, reduce oxidative damage to mitochondria, restore mitochondrial function, and help maintain normal cellular function ( 5.3 NADPH oxidases (NOXs) NOXs are the only known enzymes specifically responsible for generating ROS (Ogrunc et al., 2014)